Abstract: Novel 4-[5(and 4)-substituted-2-thienyl]-3-hydroxy-3-pyrroline-2,5-diones are disclosed which inhibit glycolic acid oxidase and thus are useful in the treatment and prevention of calcium oxalate kidney stone formation. A novel process for their preparation is also disclosed.
Type:
Grant
Filed:
November 5, 1979
Date of Patent:
February 21, 1984
Assignee:
Merck & Co., Inc.
Inventors:
Edward J. Cragoe, Jr., Clarence S. Rooney, Haydn W. R. Williams